SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs

While Pneumocystis pneumonia (PcP) still impacts the AIDS patients, it has a growing importance in immunosuppressed HIV-negative patients. To determine the anti-Pneumocystis therapeutic efficacy of new compounds, animal and in vitro models have been developed. Indeed, well-designed mouse or rat expe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Standaert-Vitse, Annie, Aliouat-Denis, Cécile-Marie, Martinez, Anna, Khalife, Sara, Pottier, Muriel, Gantois, Nausicaa, Dei-Cas, Eduardo, Aliouat, El Moukhtar
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477875/
https://ncbi.nlm.nih.gov/pubmed/26103633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0130358
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky